Evidence map›Paper›PMID 32513106›Full record

ArticleBMC bioinformatics2020

An improved clear cell renal cell carcinoma stage prediction model based on gene sets.

Fangjun Li, Mu Yang, Yunhe Li, Mingqiang Zhang, Wenjuan Wang, Dongfeng Yuan, Dongqi Tang

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fangjun LiSchool of Information Science and Engineering, Shandong University, supported by Shandong Provincial Key Laboratory of Wireless Communication Technologies, Jinan, 250100, China.
Mu YangCenter for Gene and Immunothererapy, The Second Hospital of Shandong University, Jinan, 250033, China.
Yunhe LiSchool of Information Science and Engineering, Shandong University, supported by Shandong Provincial Key Laboratory of Wireless Communication Technologies, Jinan, 250100, China.
Mingqiang ZhangSchool of Information Science and Engineering, Shandong University, supported by Shandong Provincial Key Laboratory of Wireless Communication Technologies, Jinan, 250100, China.
Wenjuan WangCenter for Gene and Immunothererapy, The Second Hospital of Shandong University, Jinan, 250033, China.
Dongfeng YuanSchool of Information Science and Engineering, Shandong University, supported by Shandong Provincial Key Laboratory of Wireless Communication Technologies, Jinan, 250100, China. dfyuan@sdu.edu.cn.
Dongqi TangCenter for Gene and Immunothererapy, The Second Hospital of Shandong University, Jinan, 250033, China. tangdq@sdu.edu.cn.

Funding

Major Science and Technology Innovation Project of Shandong Province 2018YFJH0503National Natural Science Foundation of China 61671278National Natural Science Foundation of China 81570407, 81970743the Key Research and Development Program of Shandong Province 2016CYJS01A04
6 · The paper itself

Abstract

backgroundClear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma and accounts for cancer-related deaths. Survival rates are very low when the tumor is discovered in the late-stage. Thus, developing an efficient strategy to stratify patients by the stage of the cancer and inner mechanisms that drive the development and progression of cancers is critical in early prevention and treatment.

resultsIn this study, we developed new strategies to extract important gene features and trained machine learning-based classifiers to predict stages of ccRCC samples. The novelty of our approach is that (i) We improved the feature preprocessing procedure by binning and coding, and increased the stability of data and robustness of the classification model. (ii) We proposed a joint gene selection algorithm by combining the Fast-Correlation-Based Filter (FCBF) search with the information value, the linear correlation coefficient, and variance inflation factor, and removed irrelevant/redundant features. Then the logistic regression-based feature selection method was used to determine influencing factors. (iii) Classification models were developed using machine learning algorithms. This method is evaluated on RNA expression value of clear cell renal cell carcinoma derived from The Cancer Genome Atlas (TCGA). The results showed that the result on the testing set (accuracy of 81.15% and AUC 0.86) outperformed state-of-the-art models (accuracy of 72.64% and AUC 0.81) and a gene set FJL-set was developed, which contained 23 genes, far less than 64. Furthermore, a gene function analysis was used to explore molecular mechanisms that might affect cancer development.

conclusionsThe results suggested that our model can extract more prognostic information, and is worthy of further investigation and validation in order to understand the progression mechanism.

Indexed as

Machine LearningArea Under CurveCarcinoma, Renal CellFemaleHumansKidney NeoplasmsLogistic ModelsNeoplasm StagingRNAROC CurveRNACancer stageClear cell renal cell carcinomaFeature selectionMachine learning

Identifiers

PMID32513106
PMCPMC7278205

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.